| Name | SDB-005 |
|---|
| Formal Name | Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate |
|---|
| SMILES | O=C(Oc2cccc1ccccc12)c4nn(CCCCC)c3ccccc34 |
|---|
| InChI Key | JBVNFKZVDLFOAY-UHFFFAOYAL |
|---|
| InChI Code | InChI=1/C23H22N2O2/c1-2-3-8-16-25-20-14-7-6-13-19(20)22(24-25)23(26)27-21-15-9-
11-17-10-4-5-12-18(17)21/h4-7,9-15H,2-3,8,16H2,1H3 |
|---|
| Description | SDB-005 is an indazole-based synthetic cannabinoid analog of JWH-018 in which the naphthoyl group has been replaced with a naphthyl ester at the 3 position of the indazole. Biological and toxicological data have not been reported for this compound. It should be noted that the nomenclature of SDB-005 is variable from scholarly publications to the commercial reference standard and illicit drug websites. Banister et al. categorize SDB-005 as an analogue of SDB-006, an n-alkylindole with an amide linking the 3 position to a benzyl group. The difference between the two being a benzyl versus a phenyl substituent proximal to the amide linker. However, the structure provided in this publication is the common structure listed on illicit drug vendor websites. |
|---|
Status |
Verified |
|---|
| Submitted | 2015-07-01 |
|---|
| Submitted By | Cayman Chemical
Queensland Health Forensic and Scientific Services Data |
|---|
| Published | 2015-08-05 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the SDB-005 Monograph |
|---|
|
|
